Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed3
Terminated1
Other2

Role Distribution

Principal Investigator4
Other Roles2
PI Rate67%

Activity Timeline

Clinical Trials (6)

NCT05286255Phase 1Withdrawn
Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias
COVID-19 PneumoniaViral Pneumonia
PrincipalinvestigatorStart date: 2024-10-01
NCT05297812Active Not Recruiting
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
Alpha 1-Antitrypsin DeficiencyGenetic Disease
StudychairStart date: 2022-03-23
NCT02810327Completed
Alpha-1 Carrier Genomics Study
Alpha-1 Antitrypsin DeficiencyCOPDEmphysema+1 more
PrincipalinvestigatorStart date: 2015-02-01
NCT00515164Phase 2Completed
US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
Chronic Obstructive Pulmonary DiseasePulmonary Emphysema
Principalinvestigator

Research Network

Collaboration Network

12 collaborators·44 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeanine M D'Armiento, MD, PhD

Columbia University

Related
1 trials

Shared therapeutic areas:

alpha 1-Antitrypsin DeficiencyHereditary Diseases

Worked with same sponsors:

Alpha-1 FoundationColumbia University+1 more
Collaborated on 1 trial
Similarity Score24%

Sanjiv Tewari, MD

Akron Medical Center, Akron, OH

Related
2 trials

Shared therapeutic areas:

Pulmonary Disease, Chronic ObstructivePulmonary Emphysema

Worked with same sponsors:

Aeris Therapeutics
Collaborated on 1 trial
Similarity Score24%

Thomas Gildea, MD

Pulmonary, Allergy & Critical Care Medicine, Cleveland Clinic, Cleveland, OH

Related
1 trials

Shared therapeutic areas:

Pulmonary Disease, Chronic ObstructivePulmonary Emphysema

Worked with same sponsors:

Aeris Therapeutics
Collaborated on 1 trial
Similarity Score24%

Geoffrey McLennan, MD

University of Iowa Hospitals & Clinics, Iowa City, IA

Related
2 trials

Shared therapeutic areas:

Pulmonary Disease, Chronic ObstructivePulmonary Emphysema

Worked with same sponsors:

Aeris Therapeutics
Collaborated on 1 trial
Similarity Score24%

Gerard Criner, MD

Temple University Lung Center, Philadelphia, PA

Related
2 trials

Shared therapeutic areas:

Pulmonary Disease, Chronic ObstructivePulmonary Emphysema

Worked with same sponsors:

Aeris Therapeutics
Collaborated on 1 trial
Similarity Score24%

Mark Gotfried, MD

Pulmonary Associates, Phoenix, AZ

Related
2 trials

Shared therapeutic areas:

Pulmonary Disease, Chronic ObstructivePulmonary Emphysema

Worked with same sponsors:

Aeris Therapeutics
Collaborated on 1 trial
Similarity Score24%

Mark Krasna, MD

St Joseph's Medical Center, Towson, MD

Related
1 trials

Shared therapeutic areas:

Pulmonary Disease, Chronic ObstructivePulmonary Emphysema

Worked with same sponsors:

Aeris Therapeutics
Collaborated on 1 trial
Similarity Score24%

William Leeds, DO

Veritas Clinical Specialties, Topeka, KS

Related
2 trials

Shared therapeutic areas:

Pulmonary Disease, Chronic ObstructivePulmonary Emphysema

Worked with same sponsors:

Aeris Therapeutics
Collaborated on 1 trial
Similarity Score24%

Ronald G Crystal, MD

Weill Medical College of Cornell University

Related
21 trials

Shared therapeutic areas:

Pulmonary Disease, Chronic ObstructiveSmokingalpha 1-Antitrypsin Deficiency+1 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score13%

Christelle Haziza, PhD

Philip Morris Products S.A.

Related
27 trials

Shared therapeutic areas:

SmokingPulmonary Disease, Chronic Obstructive
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT05286255Phase 1PrincipalInvestigator

Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias

COVID-19 PneumoniaViral Pneumonia
Withdrawn
NCT05297812StudyChair

Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease

Alpha 1-Antitrypsin DeficiencyGenetic Disease
Active Not Recruiting
NCT02810327PrincipalInvestigator

Alpha-1 Carrier Genomics Study

Alpha-1 Antitrypsin DeficiencyCOPDEmphysema+1 more
Completed
NCT00515164Phase 2PrincipalInvestigator

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Chronic Obstructive Pulmonary DiseasePulmonary Emphysema
Completed
NCT00532805StudyChair

The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency

Alpha-1 Antitrypsin Deficiency
Completed
NCT01608490Not ApplicablePrincipalInvestigator

Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study

Emphysema
Terminated

All 6 trials loaded